Nucleic acid molecule encoding antigen associated with lyme disease
AssigneesMax-Planck-Gesellschaft zur Forderung der Wissenscaften E.V., Deutsches Krebsforschun Zentrum Stiftung des Offentlichen Rechts
InventorsMarkus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
Life of this patent
Estimating the term…
Abstract
A vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
Claims6
An isolated nucleic acid molecule which encodes OspA of Borrelia burgdorferi, ZS7, consisting of the amino acid sequence as set forth in FIG. 1.
Dependencies are inferred from the claim text.